Infleqtion Posts Record Q2 Revenue but Shares Drop on Wider Losses and Dilution Concerns
Infleqtion posted record $12.6M Q2 revenue (up 116%) and raised outlook to $43M.
Already have an account? Sign in.
Infleqtion posted record $12.6M Q2 revenue (up 116%) and raised outlook to $43M.
SPCE stock drops as Virgin Galactic delays first commercial Delta-class flight to February 2027, despite Q2 earnings beat and strong ticket demand.
PTC Therapeutics acquires BLA-stage ST-920, a one-time AAV gene therapy for Fabry disease, with potential U.S. launch in 2027 and strong clinical data.
With elevated expectations already high, Cisco beats on revenue and EPS while raising its full-year outlook on robust AI networking orders.